BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 9510130)

  • 21. PDGF enhances orbital fibroblast responses to TSHR stimulating autoantibodies in Graves' ophthalmopathy patients.
    van Steensel L; Hooijkaas H; Paridaens D; van den Bosch WA; Kuijpers RW; Drexhage HA; van Hagen PM; Dik WA
    J Clin Endocrinol Metab; 2012 Jun; 97(6):E944-53. PubMed ID: 22438231
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oxidative Stress and Upregulation of Antioxidant Proteins, Including Adiponectin, in Extraocular Muscular Cells, Orbital Adipocytes, and Thyrocytes in Graves' Disease Associated with Orbitopathy.
    Marique L; Senou M; Craps J; Delaigle A; Van Regemorter E; Wérion A; Van Regemorter V; Mourad M; Nyssen-Behets C; Lengelé B; Baldeschi L; Boschi A; Brichard S; Daumerie C; Many MC
    Thyroid; 2015 Sep; 25(9):1033-42. PubMed ID: 26176182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current perspectives on the role of orbital fibroblasts in the pathogenesis of Graves' ophthalmopathy.
    Dik WA; Virakul S; van Steensel L
    Exp Eye Res; 2016 Jan; 142():83-91. PubMed ID: 26675405
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Forkhead Transcription Factor FOXO1 Is Regulated by Both a Stimulatory Thyrotropin Receptor Antibody and Insulin-Like Growth Factor-1 in Orbital Fibroblasts from Patients with Graves' Ophthalmopathy.
    Kumar S; Coenen M; Iyer S; Bahn RS
    Thyroid; 2015 Oct; 25(10):1145-50. PubMed ID: 26213859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Presence of nonfunctional thyrotropin receptor variant transcripts in retroocular and other tissues.
    Paschke R; Metcalfe A; Alcalde L; Vassart G; Weetman A; Ludgate M
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1234-8. PubMed ID: 7962314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional TSH receptor in human abdominal preadipocytes and orbital fibroblasts.
    Bell A; Gagnon A; Grunder L; Parikh SJ; Smith TJ; Sorisky A
    Am J Physiol Cell Physiol; 2000 Aug; 279(2):C335-40. PubMed ID: 10912999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A drug-like antagonist inhibits thyrotropin receptor-mediated stimulation of cAMP production in Graves' orbital fibroblasts.
    Neumann S; Pope A; Geras-Raaka E; Raaka BM; Bahn RS; Gershengorn MC
    Thyroid; 2012 Aug; 22(8):839-43. PubMed ID: 22784331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thyroid transcription factor-1 in orbital adipose tissues: potential role in orbital thyrotropin receptor expression.
    Bhattacharyya KK; Coenen MJ; Bahn RS
    Thyroid; 2005 May; 15(5):422-6. PubMed ID: 15929662
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A stimulatory TSH receptor antibody enhances adipogenesis via phosphoinositide 3-kinase activation in orbital preadipocytes from patients with Graves' ophthalmopathy.
    Kumar S; Nadeem S; Stan MN; Coenen M; Bahn RS
    J Mol Endocrinol; 2011 Jun; 46(3):155-63. PubMed ID: 21321093
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of human thyrotropin receptor gene expression and immunoreactivity in human orbital tissue.
    Spitzweg C; Joba W; Hunt N; Heufelder AE
    Eur J Endocrinol; 1997 Jun; 136(6):599-607. PubMed ID: 9225723
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complete inhibition of rhTSH-, Graves' disease IgG-, and M22-induced cAMP production in differentiated orbital fibroblasts by a low-molecular-weight TSHR antagonist.
    van Zeijl CJ; van Koppen CJ; Surovtseva OV; de Gooyer ME; Plate R; Conti P; Karstens WJ; Timmers M; Saeed P; Wiersinga WM; Miltenburg AM; Fliers E; Boelen A
    J Clin Endocrinol Metab; 2012 May; 97(5):E781-5. PubMed ID: 22419705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differentiation of rat preadipocytes is accompanied by expression of thyrotropin receptors.
    Haraguchi K; Shimura H; Lin L; Endo T; Onaya T
    Endocrinology; 1996 Aug; 137(8):3200-5. PubMed ID: 8754740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The thyrotropin receptor in thyroid eye disease.
    Ludgate M; Crisp M; Lane C; Costagliola S; Vassart G; Weetman A; Daunerie C; Many MC
    Thyroid; 1998 May; 8(5):411-3. PubMed ID: 9623732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TSH receptor expression in orbital tissue and its role in the pathogenesis of Graves' ophthalmopathy.
    Bahn RS
    J Endocrinol Invest; 2004 Mar; 27(3):216-20. PubMed ID: 15164996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Slit2 Modulates the Inflammatory Phenotype of Orbit-Infiltrating Fibrocytes in Graves' Disease.
    Fernando R; Grisolia ABD; Lu Y; Atkins S; Smith TJ
    J Immunol; 2018 Jun; 200(12):3942-3949. PubMed ID: 29752312
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Substitutions of different regions of the third cytoplasmic loop of the thyrotropin (TSH) receptor have selective effects on constitutive, TSH-, and TSH receptor autoantibody-stimulated phosphoinositide and 3',5'-cyclic adenosine monophosphate signal generation.
    Kosugi S; Okajima F; Ban T; Hidaka A; Shenker A; Kohn LD
    Mol Endocrinol; 1993 Aug; 7(8):1009-20. PubMed ID: 7901757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A small molecule antagonist inhibits thyrotropin receptor antibody-induced orbital fibroblast functions involved in the pathogenesis of Graves ophthalmopathy.
    Turcu AF; Kumar S; Neumann S; Coenen M; Iyer S; Chiriboga P; Gershengorn MC; Bahn RS
    J Clin Endocrinol Metab; 2013 May; 98(5):2153-9. PubMed ID: 23482611
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for an association between thyroid-stimulating hormone and insulin-like growth factor 1 receptors: a tale of two antigens implicated in Graves' disease.
    Tsui S; Naik V; Hoa N; Hwang CJ; Afifiyan NF; Sinha Hikim A; Gianoukakis AG; Douglas RS; Smith TJ
    J Immunol; 2008 Sep; 181(6):4397-405. PubMed ID: 18768899
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TSH/IGF-1 Receptor Cross Talk in Graves' Ophthalmopathy Pathogenesis.
    Krieger CC; Place RF; Bevilacqua C; Marcus-Samuels B; Abel BS; Skarulis MC; Kahaly GJ; Neumann S; Gershengorn MC
    J Clin Endocrinol Metab; 2016 Jun; 101(6):2340-7. PubMed ID: 27043163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of Endogenous Putative TSH Binding Protein in Orbit.
    Draman MS; Grennan-Jones F; Taylor P; Muller I; Evans S; Haridas A; Morris DS; Rees DA; Lane C; Dayan C; Zhang L; Ludgate M
    Curr Issues Mol Biol; 2021 Oct; 43(3):1794-1804. PubMed ID: 34889904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.